Helsinki 11th of October 2011. MediSapiens Ltd and Bayer HealthCare Pharmaceuticals have agreed to develop a platform for genomics data management and analysis in Oncology. The platform will enable Bayer to more effectively utilize genomics data in Oncology research, such utilization to be conducted in compliance with respective patients' informed consent and applicable laws and regulations.

“Genomics data is increasingly used both in pre-clinical and clinical research, but lacks software tools that can be adapted to various research environments. Our flexible platform and know-how in designing software for demanding bioinformatics environments will be tailored to meet the needs of Oncology ...

Helsinki 29.9.2011 - MediSapiens Ltd, a Finnish bioinformatics company, has released the most comprehensive map of human gene expression yet for public use. The data is available through a graphical tool, Transcriptome Viewer, at the home page of MediSapiens Ltd, allowing exploration of the expression activity of genes across chromosomes in tens of healthy human tissues. Since the sequencing of the human genome, understanding which genes are expressed in which tissues and diseases has been recognized as a key step towards understanding the genes' functions. From a genetic point of view the expression activity of a gene is a ...

MediSapiens Ltd and the Institute for Molecular Medicine Finland (FIMM), University of Helsinki have signed an agreement providing full access to IST Online 2.0 for all scientists in FIMM.